What We're Reading: Page 336
Industry reads hand-picked by our editors
May 10, 2016
May 09, 2016
-
Bloomberg
Valeant Reiterates Quarterly Outlook, Sees Filing on Time
-
Reuters
Gates Foundation backs Takeda polio vaccine with $38 million grant
-
LA Times
Purdue Pharma issues statement on OxyContin report; L.A. Times responds
-
Reuters
China regulator to launch probe into foreign, local drug firms: China Daily
May 06, 2016
-
Wall Street Journal
Knockoffs of Biotech Drugs Bring Paltry Savings
-
The Economist
Encore une fois
-
LA Times
'You Want a Description of Hell?' Oxycontin's 12-Hour Problem
-
Bloomberg
Glaxo’s CEO Search Will Be ‘Relatively Expensive,’ Chairman Says
May 05, 2016
May 04, 2016
-
MIT Technology Review
The World’s Most Expensive Medicine Is a Bust
-
Reuters
Biotech stock swoon sparks buyout interest: investor
-
FierceBiotech
NICE gives PTC, NHS more time to agree Duchenne drug price
-
Wall Street Journal
Videogamers Are Recruited to Fight Tuberculosis and Other Ills
Previous
